1290629-66-1

Basic information

• Product Name: 6-bromo-1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinoline
• Synonyms: 6-bromo-1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinoline
• CAS NO: 1290629-66-1
• Molecular Weight: 332.24
• Mol File: 1290629-66-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 6-bromo-1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 6-bromo-1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinoline(1290629-66-1)
• EPA Substance Registry System: 6-bromo-1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinoline(1290629-66-1)

Safety Data

• Hazardous Substances Data: 1290629-66-1(Hazardous Substances Data)

Upstream product

• 22190-35-8 6-bromo-1,2,3,4-tetrahydroquinoline 
• 824-94-2 p-methoxybenzyl chloride 

Downstream Products

• 1291093-98-5 (5-bromo-2-chloro-phenyl)-[1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinolin-6-yl]-methanol 
• 1291093-99-6 6-(5-bromo-2-chloro-benzyl)-1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinoline 
• 1291094-00-2 (2S,3R,4S,5S,6R)-2-{4-chloro-3-[1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinolin-6-ylmethyl]-phenyl}-6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol 
• 1291094-01-3 (2S,3R,4R,5S,6R)-2-{4-chloro-3-[1-(4-methoxy-benzyl)-1,2,3,4-tetrahydro-quinolin-6-ylmethyl]-phenyl}-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol 
• 1291094-02-4 (2S,3R,4R,5S,6R)-2-{4-chloro-3-[1,2,3,4-tetrahydro-quinolin-6-ylmethyl]-phenyl}-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol 

Relevant articles and documents

GLYCOSIDE DERIVATIVE AND USES THEREOF

This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.

GLYCOSIDE DERIVATIVES AND USES THEREOF

This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment